Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Davey

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The New England Journal of Medicine|July 23, 2019
Neural-Tube Defects and Antiretroviral Treatment Regimens in BotswanaRebecca Zash, Lewis Holmes, Modiegi Diseko, et al.
JCO Global Oncology|September 22, 2023
Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country SettingSurbhi Grover, Emily MacDuffie, Memory Nsingo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 21, 2020
Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in BotswanaSonya Davey, Gbolahan Ajibola, Kenneth Maswabi, et al.
Transplantation and Cellular Therapy|March 11, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy RecipientsMuneerah M Aleissa, Jessica S Little, Sonya Davey, et al.
Immunotherapy|September 1, 2025
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical studyStephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2024
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitisStephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The New England Journal of Medicine|July 23, 2019
Neural-Tube Defects and Antiretroviral Treatment Regimens in BotswanaRebecca Zash, Lewis Holmes, Modiegi Diseko, et al.
JCO Global Oncology|September 22, 2023
Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country SettingSurbhi Grover, Emily MacDuffie, Memory Nsingo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 21, 2020
Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in BotswanaSonya Davey, Gbolahan Ajibola, Kenneth Maswabi, et al.
Transplantation and Cellular Therapy|March 11, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy RecipientsMuneerah M Aleissa, Jessica S Little, Sonya Davey, et al.
Immunotherapy|September 1, 2025
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical studyStephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2024
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitisStephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
Pageof 3